Laboratory Surveillance for Factor XIII Deficiency

To provide support for Factor XIII testing to accurately diagnose patients in the United States in order to enhance the surveillance of rare bleeding disorders.
Funding Partners:
  • Novo Nordisk Inc.
Program Partners:
  • CDC's National Center on Birth Defects and Developmental Disabilities
Program Location:
  • United States of America